International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 943-949 , 1 November 2000

The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy

Presented at ASTRO, October 1997, Orlando, FL (USA).

  • Kathleen A Szelei-Stevens, M.D.

      Affiliations

    • Louisiana State University School of Medicine, New Orleans, LA, USA
    • Corresponding Author InformationReprint requests to: Dr. Kathleen A. Szelei-Stevens, 4920 Purdue Drive, Metairie, LA 70003
    • ,
  • Robert R Kuske, M.D.

      Affiliations

    • Ochsner Clinic, New Orleans, LA, USA
    • ,
  • Valerie A Yantsos, M.D.

      Affiliations

    • University of Texas at Dallas, Dallas, TX, USA
    • ,
  • Gunnar J Cederbom, M.D.

      Affiliations

    • Ochsner Clinic, New Orleans, LA, USA
    • ,
  • John S Bolton, M.D.

      Affiliations

    • Ochsner Clinic, New Orleans, LA, USA
    • ,
  • Barbara B Fineberg, B.A.

      Affiliations

    • Ochsner Clinic, New Orleans, LA, USA

,Accepted 23 May 2000.

References 

  1. Kuske RR, Bean JM, Garcia DM, et al.  Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1993;26:391–396
  2. Colditz GA, Willett WC, Hunter DJ, et al.  Family history, age, and risk of breast cancer (Prospective data from the nurses’ health study). JAMA. 1993;270:338–343
  3. Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer. 1985;56:3830–3837
  4. Hiramatsu H, Bornstein B, Recht A, et al.  Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ (Possible importance of family history). Cancer J Sci Am. 1995;1:55–61
  5. Fisher B, et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer (Findings from the National Surgical Adjuvant Breast and Bowel Project B-17). J Clin Oncol. 1998;16:441–452
  6. Fisher ER, Costantino J, Fisher B, et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer. 1995;75:1310–1319
  7. Brown MB, Engelman L, Jennrich RL. BMDP statistical software manual. Dixon WJ, editor. Berkeley: University of California Press; 1993.
  8. Cox DR, Oakes D. Analysis of survival data. Chapman and Hall; 1984.
  9. Early Breast Cancer Trialists Collaborative Group . Effects of radiotherapy and surgery in early breast cancer. N Engl J Med. 1995;333:1444–1455
  10. Solin LJ, I-Tien Y, Kurtz J, et al.  Ductal carcinoma in situ (Intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Cancer. 1993;71:2532–2542
  11. Chung M, Chang HR, Bland KI, et al.  Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77:97–103
  12. Kurtz JM, Jacquemier J, Amalric R, et al.  Why are local recurrences after breast-conserving therapy more frequent in younger patients?. J Clin Oncol. 1990;8:591–598
  13. Silverstein MJ, Lagios MD, Craig PH, et al.  A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267–2274
  14. Schnitt SJ, Harris JR, Smith BL. Developing a prognostic index for ductal carcinoma in situ of the breast (are we there yet?). Cancer. 1996;77:2189–2192
  15. Scott MA, Lagios MD, Axelsson K, et al.  Ductal carcinoma in situ of the breast (reproducibility of histological subtype analysis). Hum Pathol. 1997;28:967–973
  16. Silverstein MJ, Lagios MD, Groshen S, et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  17. Marcus JN, Watson P, Page DL, et al.  Hereditary breast cancer (Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage). Cancer. 1996;77:697–709
  18. Claus EB, Schildkraut JM, Thompson WD, et al.  The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77:2318–2324
  19. Krainer M, Silva-Arrieta S, FitzGerald MG, et al.  Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997;336:1416–1421
  20. FitzGerald MG, MacDonald DJ, Krainer M, et al.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996;334:143–149
  21. Langston AA, Malone KE, Thompson JD, et al.  BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996;334:137–142
  22. Saetersdal A, Dorum A, Heimdal K, et al.  Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk. Anticancer Res. 1996;16:1989–1992
  23. Weber B. Genetic testing for breast cancer. Sci Am Sci Med. 1996;3:12–15
  24. Gail MH, Brinton LA, Byar DP, et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886
  25. Lapham EV, Kozma C, Weiss JO. Genetic discrimination (Perspectives of consumers). Science. 1996;274:621–624
  26. Rothenberg KH. Genetic information and health insurance (State legislative approaches). J Law Med Ethics. 1995;23:312–319
  27. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med. 1994;154:609–616
  28. American Society of Clinical Oncology . Statement on genetic testing for cancer susceptibility. J Clin Oncol. 1996;14:1730–1736
  29. Berry DA, Parmigiani G, Sanchez J, et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst. 1997;89:227–238

☆ Financial support: Grant from the National Cancer Institute Student Summer Research Program.

PII: S0360-3016(00)00715-X

International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 943-949 , 1 November 2000

Article Tools

* Image Usage & Resolution